Prognostic value of programmed death ligand 1 (PD-L1) in glioblastoma: a systematic review, meta-analysis and validation based on dataset

Excellent prognostic value of programmed death ligand 1 (PD-L1) is observed in patients with other cancers; however, the prognostic value of PD-L1 in glioblastoma (GBM) remains unclear. Therefore, this meta-analysis evaluated the prognostic value of PD-L1 in GBM. We performed a systematic search in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huan, Xiao, Youchao, Ren, Xingguang, Wan, Dahai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809998/
https://www.ncbi.nlm.nih.gov/pubmed/34903133
http://dx.doi.org/10.1080/21655979.2021.1996515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809998/
https://www.ncbi.nlm.nih.gov/pubmed/34903133
http://dx.doi.org/10.1080/21655979.2021.1996515

Ejemplares similares